HUMANIGEN, INC.
HGEN
HGEN was delisted on the 25th of July, 2023.
1 hedge funds and large institutions have $20 invested in HUMANIGEN, INC. in 2023 Q4 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and 2 closing their positions.
67% less funds holding
Funds holding: 3 → 1 (-2)
96% less capital invested
Capital invested by funds: $509 → $20 (-$489)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DWP
Daymark Wealth Partners
Cincinnati,
Ohio
|
-$161 |
| 2 |
CIBC Private Wealth Group
Atlanta,
Georgia
|
-$129 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
TCM
1
Triumph Capital Management
Denver,
Colorado
| $20 | – | – | – |
|
|
DWP
2
Daymark Wealth Partners
Cincinnati,
Ohio
| – | -$161 | -12,500 | Closed |
|
|
3
CIBC Private Wealth Group
Atlanta,
Georgia
| – | -$129 | -10,000 | Closed |
|
HGEN Hedge Fund Activity: Q4 2023 in Review
1 of the 6,860 institutional investors tracked by Wall St. Rank reported a position in HUMANIGEN, INC. (HGEN) for Q4 2023, worth a combined $20 — down 96% from $509 a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of HGEN and 0 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Daymark Wealth Partners, exiting entirely with an estimated $161 sold.
- 1 institutional investor held HUMANIGEN, INC. (HGEN) as of Q4 2023, down from 3 in Q3 2023.
- Funds reported $20 of HUMANIGEN, INC. stock for Q4 2023, down 96% quarter-over-quarter.
- 0 funds opened new HUMANIGEN, INC. positions in Q4 2023 and 2 closed out, a net change of -2 holders.
- The largest HUMANIGEN, INC. seller in Q4 2023 was Daymark Wealth Partners, an estimated $161 sold.
Based on aggregated 13F filings for Q4 2023.